Literature DB >> 30715221

Reply to Koehler et al.

Maya Beganovic1,2, Megan K Luther1,2,3, Louis B Rice4,5, Cesar A Arias6,7, Michael J Rybak8,9,10, Kerry L LaPlante1,2,3,5.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30715221      PMCID： PMC6938205          DOI： 10.1093/cid/ciz057

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  16 in total

1.  Enterococcal endocarditis. Report of nineteen cases with long-term follow-up data.

Authors:  M G KOENIG; D KAYE
Journal:  N Engl J Med       Date:  1961-02-09       Impact factor: 91.245

2.  Infective endocarditis: a review of 125 cases from the University of Washington Hospitals, 1963-72.

Authors:  L L Pelletier; R G Petersdorf
Journal:  Medicine (Baltimore)       Date:  1977-07       Impact factor: 1.889

3.  Combination Antimicrobial Therapy for Enterococcus faecalis Infective Endocarditis.

Authors:  Philipp Koehler; Norma Jung; Oliver A Cornely; Jan Rybniker; Gerd Fätkenheuer
Journal:  Clin Infect Dis       Date:  2019-08-16       Impact factor: 9.079

4.  Endocarditis due to group D streptococci. Comparison of disease caused by streptococcus bovis with that produced by the enterococci.

Authors:  R C Moellering; B K Watson; L J Kunz
Journal:  Am J Med       Date:  1974-08       Impact factor: 4.965

5.  Synergy of penicillin and gentamicin against Enterococci.

Authors:  R C Moellering; C Wennersten; A N Weinberg
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

6.  High dose ampicillin for the treatment of high-level aminoglycoside resistant enterococcal endocarditis.

Authors:  B L Jones; H A Ludlam; D F Brown
Journal:  J Antimicrob Chemother       Date:  1994-04       Impact factor: 5.790

7.  Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.

Authors:  C Thauvin; G M Eliopoulos; S Willey; C Wennersten; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

Review 8.  A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis.

Authors:  Maya Beganovic; Megan K Luther; Louis B Rice; Cesar A Arias; Michael J Rybak; Kerry L LaPlante
Journal:  Clin Infect Dis       Date:  2018-07-02       Impact factor: 9.079

9.  Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis.

Authors:  W R Wilson; C J Wilkowske; A J Wright; M A Sande; J E Geraci
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

10.  Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis.

Authors:  Nuria Fernández-Hidalgo; Benito Almirante; Joan Gavaldà; Mercè Gurgui; Carmen Peña; Arístides de Alarcón; Josefa Ruiz; Isidre Vilacosta; Miguel Montejo; Nuria Vallejo; Francisco López-Medrano; Antonio Plata; Javier López; Carmen Hidalgo-Tenorio; Juan Gálvez; Carmen Sáez; José Manuel Lomas; Marco Falcone; Javier de la Torre; Xavier Martínez-Lacasa; Albert Pahissa
Journal:  Clin Infect Dis       Date:  2013-02-07       Impact factor: 9.079
View more
  1 in total

1.  Ampicillin-Ceftriaxone vs Ampicillin-Gentamicin for Definitive Therapy of Enterococcus faecalis Infective Endocarditis: A Propensity Score-Matched, Retrospective Cohort Analysis.

Authors:  Niyati H Shah; Kathleen A Shutt; Yohei Doi
Journal:  Open Forum Infect Dis       Date:  2021-03-06       Impact factor: 3.835
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.